Gujarat Inject Stock Screener | Share Price & Fundamental Analysis
GUJINJEC
Pharmaceuticals
Screen Gujarat Inject share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹39.59
▼
-0.08 (-0.20%)
Market Cap
₹48.99 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.75
EPS (TTM)
₹0.70
Dividend Yield
-
Debt to Equity
0.08
52W High
₹39.67
52W Low
₹18.51
Operating Margin
4.00%
Profit Margin
8.33%
Revenue (TTM)
₹12.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹12.00
Total Equity
₹10.00
Gujarat Inject Share Price History - Stock Screener Chart
Screen GUJINJEC historical share price movements with interactive charts. Analyze price trends and patterns.
Gujarat Inject Company Profile - Fundamental Screener
Screen Gujarat Inject company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GUJINJEC shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE659F01014
Gujarat Inject Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GUJINJEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 12 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 12 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 9 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Share Capital | 15 | 11 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | -5 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 |
Screen GUJINJEC income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 19 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Expenses | 11 | 18 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| EBITDA | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 4.00% | 6.00% | 1.00% | -217.00% | -200.00% | -982.00% | 0.00% | 0.00% | 0.00% | 1.00% | 4.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.30 | 0.70 | 0.09 | 0.05 | 0.00 | -0.12 | 0.00 | -0.01 | -0.03 | 0.02 | 4.70 | -0.01 |
Gujarat Inject Cash Flow Screener - Liquidity Fundamentals
Screen GUJINJEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen GUJINJEC shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Apr | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 83.95% | 83.95% | 92.83% | 88.24% | 86.82% | 86.79% | 86.80% | 85.91% |
| Other Holding | 16.05% | 16.05% | 7.17% | 11.75% | 13.18% | 13.21% | 13.20% | 14.08% |
| Shareholder Count | 7,303 | 7,303 | 8,151 | 6,721 | 6,706 | 6,698 | 6,627 | 6,773 |
Gujarat Inject Dividend Screener - Share Yield Analysis
Screen GUJINJEC dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Gujarat Inject Index Membership - Market Screener Classification
Screen GUJINJEC by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Gujarat Inject Market Events Screener - Corporate Actions
Screen GUJINJEC market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.00% | ||
| Annual General Meeting | NA | -0.40% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 2.08% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 1.33% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 3.73% |
| 2025-04-03 | 2025-04-03 | Extraordinary General Meeting | NA | 0.15% |
| 2025-02-18 | 2025-02-18 | Change Of Name | NA | 0.00% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -0.08% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | -4.95% |
| 2024-01-20 | 2024-01-20 | Extraordinary General Meeting | NA | 10.00% |
Gujarat Inject Competitors Screener - Peer Comparison
Screen GUJINJEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Gujarat Inject Company Announcements - News Screener
Screen GUJINJEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-09 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025 | View |
| 2025-11-13 | UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025. | View |
| 2025-11-10 | Board Meeting Intimation for Un-Audited Financial Results (Standalone) Of The Company For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report Of The Statutory Auditors Thereon; | View |
| 2025-10-30 | Board Meeting Outcome for Outcome Of Board Meeting Dated Thursday 30Th October 2025 | View |
| 2025-10-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-01 | Closure of Trading Window | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-10 | Reg. 34 (1) Annual Report. | View |
| 2025-09-10 | Notice Of 34Th Annual General Meeting Along With Annual Report Of The Company For F.Y. 2024-25. | View |
| 2025-09-08 | Board Meeting Outcome for Change Of Object Of The Company. | View |
| 2025-08-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 14Th August 2025 | View |
| 2025-08-14 | FINANCIAL RESULTS 30.06.2025 | View |
| 2025-08-11 | Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June 2025 | View |
| 2025-07-25 | Revised Outcome Of The Board Meeting Held On 07Th July 2025 | View |
| 2025-07-15 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2025-07-07 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-07-07 | Board Meeting Outcome for Outcome Of Board Meeting Dated 07Th July 2025 | View |
| 2025-07-01 | Closure of Trading Window | View |